Renewal-NAD+: A Study of Oral NAD+ and Its Multi-omic Impact in a Healthy Cohort

Clinical trial NCT07336836 · COMPLETED

Trial details

NCT number: NCT07336836
Sponsor: BioNADrx Holdings, Inc. Bryleos
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Health Adult Subjects Healthy Participants

Start date: 2022-02-23
Primary completion: 2022-06-04
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.